Who are Mironid's investors?

Mironid's investors include BioGeneration Ventures, Epidarex Capital, Roche Venture Fund, Sofinnova Partners, Scottish National Investment Bank.

Mironid

5 known investors

Find your way into Mironid

Paths you didn't know you had: your email and LinkedIn already hold routes to the Mironid team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Mironid is a drug development company building a pipeline of therapies targeting cAMP-degrading phosphodiesterase enzymes to treat Autosomal Dominant Polycystic Kidney Disease (ADPKD) and other rare kidney diseases. It focuses on developing novel therapeutics for rare diseases with high unmet clinical need.

Biotech Medical Devices

Founders & leadership

Adele RowleyChief Scientific Officer

Investors · 5

BioGeneration Ventureslisted by BioGeneration VenturesNaarden

How we know: BioGeneration Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Epidarex Capitallisted by Epidarex CapitalBethesda · $2.5M – $6.3M

How we know: Epidarex Capital's portfolio page · funding news feeds · open dataset · 5k.vc investor directory · Not right? Tell us

Roche Venture Fundlisted by Roche Venture FundBasel · $648K – $3.2M

How we know: Roche Venture Fund's portfolio page · funding news feeds · open dataset · 5k.vc investor directory · Not right? Tell us

Sofinnova Partnerslisted by Sofinnova PartnersParis · $540K – $27M

How we know: Sofinnova Partners's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Scottish National Investment BankreportedEdinburgh · $1.3M

How we know: funding news feeds · Not right? Tell us

Related companies · 5

Rif CareRif Care is a menstrual care brand offering plant-based period products.

MedpagetodayMedPage Today is a clinical news and information platform that provides independent coverage of medical research, healthcare policy, and professional development for U.S. healthcare practitioners. The platform publishes daily clinical news, conference coverage, investigative reports, and podcasts with strict editorial review and fact-checking standards.

WomenshealthmagWomen's Health is a media brand publishing articles, guides, podcasts, and video series on fitness, nutrition, beauty, and health topics aimed at women. It also offers subscription-based (WH+) workout and nutrition plans covering strength training, muscle building, and longevity.

TodayTODAY is a morning news and lifestyle broadcast program and digital platform that delivers news, entertainment, wellness content, and lifestyle advice to American audiences. The company operates both a television show and TODAY.com, a digital destination offering news coverage, recipes, health tips, and product recommendations.

The LanbyThe Lanby curates and recommends wellness products from third-party brands across categories including supplements, fitness equipment, kitchen items, and home goods aligned with holistic health principles. The company serves consumers seeking quality wellness essentials and personalized long-term health partnerships.

Companies working in the same space as Mironid.

In the news

Glasgow-based Mironid raises €39.9 million in Series B to advance rare kidney disease treatmenteu-startups.com · Aug 2026

Frequently asked questions

What does Mironid do?: Mironid is a drug development company building a pipeline of therapies targeting cAMP-degrading phosphodiesterase enzymes to treat Autosomal Dominant Polycystic Kidney Disease (ADPKD) and other rare kidney diseases. It focuses on developing novel therapeutics for rare diseases with high unmet clinical need.
Who are Mironid's investors?: Mironid's investors include BioGeneration Ventures, Epidarex Capital, Roche Venture Fund, Sofinnova Partners, Scottish National Investment Bank.